Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Coadaptation of Helicobacter pylori and humans: ancient history, modern implications
John C. Atherton, Martin J. Blaser
John C. Atherton, Martin J. Blaser
View: Text | PDF
Review Series

Coadaptation of Helicobacter pylori and humans: ancient history, modern implications

  • Text
  • PDF
Abstract

Humans have been colonized by Helicobacter pylori for at least 50,000 years and probably throughout their evolution. H. pylori has adapted to humans, colonizing children and persisting throughout life. Most strains possess factors that subtly modulate the host environment, increasing the risk of peptic ulceration, gastric adenocarcinoma, and possibly other diseases. H. pylori genes encoding these and other factors rapidly evolve through mutation and recombination, changing the bacteria-host interaction. Although immune and physiologic responses to H. pylori also contribute to pathogenesis, humans have evolved in concert with the bacterium, and its recent absence throughout the life of many individuals has led to new human physiological changes. These may have contributed to recent increases in esophageal adenocarcinoma and, more speculatively, other modern diseases.

Authors

John C. Atherton, Martin J. Blaser

×

Figure 4

Variation of interactive factors.

Options: View larger image (or click on image) Download as PowerPoint
Variation of interactive factors.
(A) Model of alternative host interact...
(A) Model of alternative host interactions according to status of mutable loci, modeled on the cag PaI. The H. pylori genome contains multiple hypermutable loci, creating many contingency genes. The status of each gene confers a particular phenotype to the H. pylori cell, affecting its host interactions. The strain on the left has an operating genetic element, which induces a greater host response; on the right is the same strain with a deleted element, inducing a lower response. The host responses create environmental constraints that select within the H. pylori population, creating a dynamic equilibrium (56). (B) Microevolution of cagA within a family. All four subjects in family F12 are colonized with strain 25, and subject D is also colonized with strain 26. Subjects C and D both have two clones of strain 25 with cagA with four and five type C (active) TPMs – these have evolved by simple duplication of the TPM-containing region. They are identical between these subjects, and so likely have been passed between them. Strain 25 in subject A possesses cagA with a variable region (VR) that is nearly identical to strain 26, implying these strains have recombined in subject D: strain 25 has acquired cagA from strain 26 and then been passed to subject A. Duplication of the TPM-C motif may have occurred within subject D or subject A. Strain 25 from subject B lacks the entire cag PaI and may have evolved by deletion from strain 25 from any family member. Solid lines indicate identical strains between hosts, whereas dashed lines represent proposed transmission. Adapted with permission from Clinical cancer research (43) (B).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts